NIFTY 50

Biocon Q3FY21: Here's what to expect

Updated : January 20, 2021 04:49 PM IST

Stock of pharma major Biocon has risen 60 percent from its March 2020 lows. The company is scheduled to report its Q3FY21 earnings tomorrow (January 21).

CNBC-TV18 poll suggest a revenue growth of 10 percent and margins are expected to come at around 25 percent.

Watch video for more.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you